SAM.gov75F40126Q22123
Open
Illumina MiSeq i100 System
- Response deadline
- May 22, 2026 Closed
- Date posted
- May 15, 2026
- Source
- Open notice
Description
This requirement is for the acquisition of one (1) Illumina MiSeq i100 Whole Genome Sequencing System for the FDA Irvine Medical Products Laboratory (IRVLMP). The procurement is being conducted on a sole-source basis under RFO FAR Part 12 and FAR 13.106-1(b)(1), as the Illumina MiSeq i100 System is the only system determined capable of meeting the Government�s minimum requirements for compatibility with existing validated laboratory workflows, consumables, sequencing methods, software environments, and operational procedures. The requirement includes associated components, software, delivery, installation, training, and manufacturer warranty support.
Classifications
Documents
No documents posted for this opportunity.
Similar contracts
- Intent to Sole Source - IntelliBlate Ximitry ProbeMarylandDue Oct 16, 2026
- Purchase a air cooled compressor and recirculator for ColdEdge cryostatDistrict of ColumbiaDue Oct 12, 2026
- Purchase of One (1) QS3 qPCR System, One (1) iBright FL1500 Imaging System, and Associated Accessories, Brand Name or Equal To for Oklahoma City VA Medical Center (OKCVAMC)OklahomaDue Oct 15, 2026
- Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical CenterMarylandDue Oct 23, 2026
- Purchase Lynx laboratory-scale floor-standing refrigerated centrifuge with the capacity to spin 6 liters of liquid to >17.5k x gDistrict of ColumbiaDue Oct 12, 2026
- Low-Range Force Frame KitDue Oct 21, 2026